<DOC>
	<DOCNO>NCT00334607</DOCNO>
	<brief_summary>The aim study confirm absence immune interference HRV vaccine routine infant vaccination currently use USA .</brief_summary>
	<brief_title>Study 2 Doses HRV Vaccine Given Concomitantly Separately With Routine Vaccinations Healthy Infants USA</brief_title>
	<detailed_description>A phase III randomize multi-center study ass immunogenicity three dos Pediarix® , Prevnar® ActHIB® give healthy infant 2 , 4 6 month age administer GlaxoSmithKline ( GSK ) Biologicals ' two-dose oral live attenuate human rotavirus ( HRV ) vaccine give vaccination visit ( 2 4 month age ) give separately ( 3 5 month age ) .</detailed_description>
	<mesh_term>Rotavirus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy infant 6 12 week old Dose 1 write informed consent . Allergic reaction vaccine component ; clinically significant history chronic GI disease ( uncorrected GI congenital malformation ) serious medical condition per investigator , receive vaccine treatment prohibit protocol ; immunocompromised .</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>16 Weeks</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>HRV vaccine</keyword>
	<keyword>diarrhoea</keyword>
	<keyword>rotavirus</keyword>
</DOC>